Which Diet-Exercise combo works best for obesity? study tests keto, fasting, and flexitarian plans
NCT ID NCT07695480
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This study looks at how different diets—ketogenic, intermittent fasting, and semi-vegetarian—affect weight, body fat, and metabolism in women with obesity, both alone and with a home exercise program. Over 6 weeks, 108 women aged 19-45 will be split into nine groups to compare results. Researchers will measure changes in weight, BMI, and blood markers like insulin and hormones to find the most effective lifestyle combination.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dietary interventions (ketogenic, intermittent fasting, semi-vegetarian) and home-based exercise
- What this could lead to
- If successful, this could show which diet-exercise combination is most effective for weight loss and metabolic health in women with obesity.
- What could go wrong
- This is a small, short-term study (6 weeks) with 108 participants, so results may not apply to all women or lead to long-term changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HORMONAL CHANGES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fırat University Hospital
Elâzığ, 23000, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test